PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions | British Journal of Cancer
PARP Inhibitors: Where Are We in 2020 and What's Coming Next?
JCI - The evolving landscape of predictive biomarkers of response to PARP inhibitors
The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment
JCM | Free Full-Text | PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
Cancers | Free Full-Text | Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors
Biomedicines | Free Full-Text | Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review - Gynecologic Oncology
Poly (ADP-ribose) polymerase (PARP) inhibitors as chemosensitizing compounds for the treatment of drug resistant cancers
An update on PARP inhibitors—moving to the adjuvant setting | Nature Reviews Clinical Oncology
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications | Molecular Cancer | Full Text
PARP inhibitors stumble in breast cancer | Nature Biotechnology
Focus on suppressive macrophages may boost effects of PARP inhibitors
Epigenetic marker contributes to PARP inhibitor resistance | Center for Cancer Research
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells: Trends in Cell Biology
Unsprung traps keep PARP inhibitors effective | Nature Cell Biology
Cancers | Free Full-Text | PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action | Science Translational Medicine
Frontiers | PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Mode of Action | OncologyPRO
Frontiers | Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect
Mechanisms of resistance to PARP inhibitors. Cancer cells develop... | Download Scientific Diagram
PARP-inhibitors: A New Generation of Cancer Drugs - YouTube
PARP inhibitor - Wikipedia
